GCA
Gradient Capital Advisors’s Immunoprecise Antibodies IPA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.4K | Hold |
26,808
| – | – | 0.01% | 161 |
|
|
2025
Q1 | $10.1K | Hold |
26,808
| – | – | ﹤0.01% | 155 |
|
|
2024
Q4 | $11K | Hold |
26,808
| – | – | ﹤0.01% | 152 |
|
|
2024
Q3 | $17.1K | Hold |
26,808
| – | – | 0.01% | 148 |
|
|
2024
Q2 | $27.1K | Hold |
26,808
| – | – | 0.01% | 140 |
|
|
2024
Q1 | $40.7K | Hold |
26,808
| – | – | 0.02% | 139 |
|
|
2023
Q4 | $45.8K | Hold |
26,808
| – | – | 0.02% | 142 |
|
|
2023
Q3 | $49.1K | Hold |
26,808
| – | – | 0.02% | 136 |
|
|
2023
Q2 | $79.4K | Hold |
26,808
| – | – | 0.03% | 139 |
|
|
2023
Q1 | $74.3K | Hold |
26,808
| – | – | 0.03% | 138 |
|
|
2022
Q4 | $140K | Hold |
26,808
| – | – | 0.06% | 133 |
|
|
2022
Q3 | $107K | Buy |
26,808
+6,808
| +34% | +$27.2K | 0.05% | 129 |
|
|
2022
Q2 | $76K | Hold |
20,000
| – | – | 0.04% | 111 |
|
|
2022
Q1 | $103K | Hold |
20,000
| – | – | 0.04% | 122 |
|
|
2021
Q4 | $107K | Sell |
20,000
-1,718
| -8% | -$9.19K | 0.04% | 120 |
|
|
2021
Q3 | $135K | Hold |
21,718
| – | – | 0.06% | 117 |
|
|
2021
Q2 | $131K | Hold |
21,718
| – | – | 0.06% | 117 |
|
|
2021
Q1 | $213K | Hold |
21,718
| – | – | 0.11% | 103 |
|
|
2020
Q4 | $325K | Buy |
+21,718
| New | +$325K | 0.19% | 82 |
|